Efficacy and Safety, Long-Term Study of NPC-16 to Treat Dysmenorrhea

Phase 3CompletedNCT02362711

Nobelpharma248 enrolled

Overview

The purpose of this long-term study is to determine whether NPC-16 is effective in the treatment of dysmenorrhea.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

248

Sex: FEMALEMin age: 16 Years

Medical Language ↔ Plain English

Inclusion Criteria: * dysmenorrhea Exclusion Criteria: * severe hepatopathy * pregnant woman

Patient Response to Treatment for Dysmenorrhea, as Evaluated by Total Dysmenorrhea Score

Time frame: 52 weeks

Patient Response to Treatment for Dysmenorrhea, as Evaluated by Visual Analogue Scale (VAS) of Dysmenorrhea

Time frame: 52 weeks

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.